Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Chemoprevention

UK data confirm protective effect of statins against liver cancer

Study from the UK has demonstrated a protective effect of statins against liver cancer. In the image, dividing cancer cells

Source: Steve Gschmeissner / Science Photo Library

A reduced risk of liver cancer has been observed in people taking statins

Statins target the production of cholesterol in the liver. There is evidence from Asia, which has high rates of liver cancer, that statins protect against this malignancy; now, a similar protective effect has been demonstrated in the UK, which has a low rate of the disease.

According to a case-control study using UK data and published in the Journal of the National Cancer Institute[1], people taking statins had a reduced risk for developing primary liver cancer. The adjusted odds ratio was 0.55 for ever-use versus non-use (95% confidence interval 0.45 to 0.69), and the effect remained significant irrespective of presence or absence of diabetes or liver disease.

“Statin use may be especially beneficial in persons at elevated risk of liver cancer,” the authors write. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067968

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.